Human Genome CEO Sees Benlysta Driving Growth

Human Genome CEO Sees Benlysta Driving Growth Play

June 27 (Bloomberg) -- Thomas Watkins, chief executive officer of Human Genome Sciences Inc., talks about Human Genome's Benlysta therapy for Lupus. Watkins also discusses drug pricing. He speaks with Shannon Pettypiece at the 2011 BIO International Convention in Washington on Bloomberg Television's "Fast Forward." (Source: Bloomberg)

blog comments powered by Disqus